Loading...

Allen C Gao

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lombard AP, Liu L, Cucchiara V, Liu C, Armstrong CM, Zhao R, Yang JC, Lou W, Evans CP, Gao A. Intra vs Inter Cross-Resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer. Mol Cancer Ther. 2018 Jun 11. PMID: 29891490.
      View in: PubMed
    2. Zhao J, Sun G, Liao B, Zhang X, Armstrong CM, Yin X, Liu J, Chen J, Yang Y, Zhao P, Tang Q, Wang Z, Chen Z, Li X, Wei Q, Li X, Chen N, Gao A, Shen P, Zeng H. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone-metastatic prostate cancer. BJU Int. 2018 May 17. PMID: 29772102.
      View in: PubMed
    3. Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao A, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj GV. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. Eur Urol. 2018 May; 73(5):715-723. PMID: 29258679.
      View in: PubMed
    4. Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, Foye A, Lloyd P, Nykter M, Beer TM, Alumkal JJ, Thomas GV, Reiter RE, Rettig MB, Evans CP, Gao A, Chi KN, Small EJ, Gleave ME. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. J Natl Cancer Inst. 2017 Dec 01; 109(12). PMID: 29206995.
      View in: PubMed
    5. Tummala R, Lou W, Gao A, Nadiminty N. Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. Mol Cancer Ther. 2017 Dec; 16(12):2770-2779. PMID: 28729398.
      View in: PubMed
    6. Lombard AP, Liu C, Armstrong CM, Cucchiara V, Gu X, Lou W, Evans CP, Gao A. ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer. Mol Cancer Ther. 2017 Oct; 16(10):2257-2266. PMID: 28698198.
      View in: PubMed
    7. Recouvreux MV, Wu JB, Gao A, Zonis S, Chesnokova V, Bhowmick N, Chung LW, Melmed S. Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells. Endocrinology. 2017 07 01; 158(7):2255-2268. PMID: 28444169.
      View in: PubMed
    8. Armstrong CM, Liu C, Lou W, Lombard AP, Evans CP, Gao A. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells. Prostate. 2017 Jun; 77(9):1020-1028. PMID: 28485104.
      View in: PubMed
    9. Liu C, Armstrong CM, Lou W, Lombard AP, Cucchiara V, Gu X, Yang JC, Nadiminty N, Pan CX, Evans CP, Gao A. Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Mol Cancer Ther. 2017 Aug; 16(8):1521-1530. PMID: 28500234.
      View in: PubMed
    10. Armstrong CM, Gao A. CCN3-EZH2-AR feedback loop: new targets for enzalutamide and castration resistant prostate cancer. J Cell Commun Signal. 2017 Mar; 11(1):89-91. PMID: 28255661.
      View in: PubMed
    11. Lin LC, Gao A, Lai CH, Hsieh JT, Lin H. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes. Cancer Lett. 2017 04 10; 391:74-82. PMID: 28109910.
      View in: PubMed
    12. Cucchiara V, Yang JC, Mirone V, Gao A, Rosenfeld MG, Evans CP. Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers (Basel). 2017 Jan 16; 9(1). PMID: 28275218.
      View in: PubMed
    13. Liu C, Armstrong CM, Lou W, Lombard A, Evans CP, Gao A. Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer. Mol Cancer Ther. 2017 01; 16(1):35-44. PMID: 27794047.
      View in: PubMed
    14. Armstrong CM, Gao A. Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer. Asian J Urol. 2016 Oct; 3(4):185-194. PMID: 28642838.
      View in: PubMed
    15. Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao A, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW. Corrigendum: ROR-? drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat Med. 2016 06 07; 22(6):692. PMID: 27270780.
      View in: PubMed
    16. Liu C, Armstrong C, Zhu Y, Lou W, Gao A. Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer. Oncotarget. 2016 May 31; 7(22):32210-20. PMID: 27049719.
      View in: PubMed
    17. Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao A, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW. ROR-? drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat Med. 2016 05; 22(5):488-96. PMID: 27019329; PMCID: PMC5030109.
    18. Tummala R, Nadiminty N, Lou W, Evans CP, Gao A. Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation. Prostate. 2016 Apr; 76(5):445-55. PMID: 26714839.
      View in: PubMed
    19. Chandrasekar T, Yang JC, Gao A, Evans CP. Targeting molecular resistance in castration-resistant prostate cancer. BMC Med. 2015 Sep 01; 13:206. PMID: 26329698; PMCID: PMC4556222.
    20. Armstrong CM, Gao A. Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies. Am J Clin Exp Urol. 2015; 3(2):64-76. PMID: 26309896; PMCID: PMC4539108.
    21. Gao A, Zhu Y. Stat5a/b in Prostate Cancer Metastasis. Am J Pathol. 2015 Sep; 185(9):2351-3. PMID: 26187549.
      View in: PubMed
    22. Nadiminty N, Tummala R, Liu C, Lou W, Evans CP, Gao A. NF-?B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer. Mol Cancer Ther. 2015 Aug; 14(8):1884-95. PMID: 26056150; PMCID: PMC4529751.
    23. Chandrasekar T, Yang JC, Gao A, Evans CP. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Transl Androl Urol. 2015 Jun; 4(3):365-80. PMID: 26814148; PMCID: PMC4708226.
    24. Zhu Y, Liu C, Armstrong C, Lou W, Sandher A, Gao A. Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer. Clin Cancer Res. 2015 Sep 15; 21(18):4133-42. PMID: 25995342; PMCID: PMC4573793.
    25. Liu C, Lou W, Armstrong C, Zhu Y, Evans CP, Gao A. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition. Prostate. 2015 Sep; 75(13):1341-53. PMID: 25970160; PMCID: PMC4536195.
    26. Liu C, Lou W, Zhu Y, Yang JC, Nadiminty N, Gaikwad NW, Evans CP, Gao A. Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer. Cancer Res. 2015 Apr 01; 75(7):1413-22. PMID: 25649766; PMCID: PMC4383695.
    27. Ghosh PM, Gao A. Zoledronic acid at the time of castration prevented castration-induced bone metastasis in mice. Endocr Relat Cancer. 2014 Oct; 21(5):C11-4. PMID: 25183429.
      View in: PubMed
    28. Zhu Y, Liu C, Cui Y, Nadiminty N, Lou W, Gao A. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). Prostate. 2014 Aug; 74(11):1086-94. PMID: 24819501.
      View in: PubMed
    29. Cui Y, Nadiminty N, Liu C, Lou W, Schwartz CT, Gao A. Upregulation of glucose metabolism by NF-?B2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells. Endocr Relat Cancer. 2014 Jun; 21(3):435-42. PMID: 24659479; PMCID: PMC4021715.
    30. Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz CT, Evans CP, Gao A. Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer. Clin Cancer Res. 2014 Jun 15; 20(12):3198-3210. PMID: 24740322; PMCID: PMC4058390.
    31. Qu S, Wang K, Xue H, Wang Y, Wu R, Liu C, Gao A, Gout PW, Collins CC, Wang Y. Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model. Mol Oncol. 2014 Mar; 8(2):311-22. PMID: 24388358.
      View in: PubMed
    32. Liu C, Zhu Y, Lou W, Cui Y, Evans CP, Gao A. Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells. Prostate. 2014 Feb; 74(2):201-9. PMID: 24307657; PMCID: PMC4437226.
    33. Zhu Y, Liu C, Tummala R, Nadiminty N, Lou W, Gao A. RhoGDIa downregulates androgen receptor signaling in prostate cancer cells. Prostate. 2013 Nov; 73(15):1614-22. PMID: 23922223; PMCID: PMC3941975.
    34. Zhu Y, Liu C, Nadiminty N, Lou W, Tummala R, Evans CP, Gao A. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther. 2013 Sep; 12(9):1829-36. PMID: 23861346; PMCID: PMC3947549.
    35. Tummala R, Nadiminty N, Lou W, Zhu Y, Gandour-Edwards R, Chen HW, Evans CP, Gao A. Lin28 promotes growth of prostate cancer cells and activates the androgen receptor. Am J Pathol. 2013 Jul; 183(1):288-95. PMID: 23790802; PMCID: PMC3702743.
    36. Nadiminty N, Tummala R, Liu C, Yang J, Lou W, Evans CP, Gao A. NF-?B2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants. Mol Cancer Ther. 2013 Aug; 12(8):1629-37. PMID: 23699654; PMCID: PMC3941973.
    37. Duan Z, Zou JX, Yang P, Wang Y, Borowsky AD, Gao A, Chen HW. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex. Prostate. 2013 Apr; 73(5):455-66. PMID: 23038103.
      View in: PubMed
    38. Liu C, Zhu Y, Lou W, Nadiminty N, Chen X, Zhou Q, Shi XB, deVere White RW, Gao A. Functional p53 determines docetaxel sensitivity in prostate cancer cells. Prostate. 2013 Mar; 73(4):418-27. PMID: 22996738; PMCID: PMC3938015.
    39. Yang P, Guo L, Duan ZJ, Tepper CG, Xue L, Chen X, Kung HJ, Gao A, Zou JX, Chen HW. Histone methyltransferase NSD2/MMSET mediates constitutive NF-?B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol Cell Biol. 2012 Aug; 32(15):3121-31. PMID: 22645312; PMCID: PMC3434505.
    40. Nadiminty N, Tummala R, Lou W, Zhu Y, Shi XB, Zou JX, Chen H, Zhang J, Chen X, Luo J, deVere White RW, Kung HJ, Evans CP, Gao A. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PLoS One. 2012; 7(3):e32832. PMID: 22479342; PMCID: PMC3316551.
    41. Ge D, Gao A, Zhang Q, Liu S, Xue Y, You Z. LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling. Prostate. 2012 Sep 01; 72(12):1306-16. PMID: 22213096; PMCID: PMC3665156.
    42. Nadiminty N, Tummala R, Lou W, Zhu Y, Zhang J, Chen X, eVere White RW, Kung HJ, Evans CP, Gao A. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem. 2012 Jan 06; 287(2):1527-37. PMID: 22128178; PMCID: PMC3256915.
    43. Zhong X, Li L, Wang M, Luo W, Tan Q, Xu F, Zhu W, Wang Q, Wang T, Hou M, Nadimity N, Xue X, Chen J, Ma W, Gao A, Zhou Q. A proteomic approach to elucidate the multiple targets of selenium-induced cell-growth inhibition in human lung cancer. Thorac Cancer. 2011 Nov; 2(4):164-178. PMID: 27755845.
      View in: PubMed
    44. Nadiminty N, Gao A. Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives. World J Urol. 2012 Jun; 30(3):287-95. PMID: 22009116.
      View in: PubMed
    45. Libertini SJ, Chen H, al-Bataina B, Koilvaram T, George M, Gao A, Mudryj M. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells. Prostate. 2012 May 01; 72(6):649-60. PMID: 21837779.
      View in: PubMed
    46. Zhu Y, Tummala R, Liu C, Nadiminty N, Lou W, Evans CP, Zhou Q, Gao A. RhoGDIa suppresses growth and survival of prostate cancer cells. Prostate. 2012 Mar; 72(4):392-8. PMID: 21681778; PMCID: PMC3961824.
    47. Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, Yang J, Evans CP, Zhou Q, Gao A. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate. 2012 Jan; 72(1):82-9. PMID: 21538419; PMCID: PMC3938016.
    48. Liu C, Liu H, Li Y, Wu Z, Zhu Y, Wang T, Gao A, Chen J, Zhou Q. Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid. Mol Carcinog. 2012 Apr; 51(4):303-14. PMID: 21520298.
      View in: PubMed
    49. Liu C, Nadiminty N, Tummala R, Chun JY, Lou W, Zhu Y, Sun M, Evans CP, Zhou Q, Gao A. Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer. Genes Cancer. 2011 Feb; 2(2):151-9. PMID: 21779488; PMCID: PMC3111248.
    50. Duleba AJ, Ahmed MI, Sun M, Gao A, Villanueva J, Conley AJ, Turgeon JL, Benirschke K, Gee NA, Chen J, Green PG, Lasley BL. Effects of triclocarban on intact immature male rat: augmentation of androgen action. Reprod Sci. 2011 Feb; 18(2):119-27. PMID: 20889956; PMCID: PMC3031453.
    51. Yang X, You J, Luo W, Yue J, Ma L, Xiao W, Zhu D, Wu Z, Wang D, Nadiminty N, Gao A, Zhou Q. The N-terminal kinase suppressor of Ras complex has a weak nucleoside diphosphate kinase activity. Thorac Cancer. 2010 09; 1(3):109-115. PMID: 27755802.
      View in: PubMed
    52. Chun JY, Tummala R, Nadiminty N, Lou W, Liu C, Yang J, Evans CP, Zhou Q, Gao A. Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer. 2010 Aug; 1(8):868-76. PMID: 21442031; PMCID: PMC3063649.
    53. Yang JC, Bai L, Yap S, Gao A, Kung HJ, Evans CP. Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone model. Mol Cancer Ther. 2010 Jun; 9(6):1629-37. PMID: 20484016.
      View in: PubMed
    54. Nadiminty N, Lou W, Sun M, Chen J, Yue J, Kung HJ, Evans CP, Zhou Q, Gao A. Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. Cancer Res. 2010 Apr 15; 70(8):3309-19. PMID: 20388792; PMCID: PMC3041633.
    55. Sun M, Lou W, Chun JY, Cho DS, Nadiminty N, Evans CP, Chen J, Yue J, Zhou Q, Gao A. Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer. 2010 Mar; 1(3):283-92. PMID: 21318089; PMCID: PMC3036540.
    56. Nadiminty N, Dutt S, Tepper C, Gao A. Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells. Prostate. 2010 Feb 15; 70(3):276-87. PMID: 19827050.
      View in: PubMed
    57. Nan J, Liu Q, Ding Y, Zhang Z, Gao A, Zhou Q. [Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non-small Cell Lung Cancer Therapy.]. Zhongguo Fei Ai Za Zhi. 2009 Dec 20; 12(12):1316-24. PMID: 20723392.
      View in: PubMed
    58. Dutt SS, Gao A. Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncol. 2009 Nov; 5(9):1403-13. PMID: 19903068; PMCID: PMC3041149.
    59. Chun JY, Nadiminty N, Dutt S, Lou W, Yang JC, Kung HJ, Evans CP, Gao A. Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res. 2009 Aug 01; 15(15):4815-22. PMID: 19638459; PMCID: PMC3041150.
    60. Feng S, Tang Q, Sun M, Chun JY, Evans CP, Gao A. Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. Mol Cancer Ther. 2009 Mar; 8(3):665-71. PMID: 19240160; PMCID: PMC3041173.
    61. Lee SO, Chun JY, Nadiminty N, Lou W, Feng S, Gao A. Interleukin-4 activates androgen receptor through CBP/p300. Prostate. 2009 Feb 01; 69(2):126-32. PMID: 18819102; PMCID: PMC3035998.
    62. Nadiminty N, Chun JY, Lou W, Lin X, Gao A. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate. 2008 Dec 01; 68(16):1725-33. PMID: 18781579.
      View in: PubMed
    63. Nadiminty N, Gao A. Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol Nutr Food Res. 2008 Nov; 52(11):1247-60. PMID: 18727008.
      View in: PubMed
    64. Hu Y, Sun M, Nadiminty N, Lou W, Pinder E, Gao A. Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun. 2008 Jun 06; 370(3):440-4. PMID: 18381203; PMCID: PMC2950805.
    65. Hanley K, Wang J, Bourne P, Yang Q, Gao A, Lyman G, Tang P. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hum Pathol. 2008 Mar; 39(3):386-92. PMID: 18187183.
      View in: PubMed
    66. Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao A. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Prostate. 2008 Jan 01; 68(1):85-91. PMID: 18008330.
      View in: PubMed
    67. Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao A. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Prostate. 2007 Sep 01; 67(12):1293-300. PMID: 17626246.
      View in: PubMed
    68. Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao A. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Mol Cancer Ther. 2007 Sep; 6(9):2572-80. PMID: 17876054; PMCID: PMC2821810.
    69. Nadiminty N, Chun JY, Hu Y, Dutt S, Lin X, Gao A. LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway. Biochem Biophys Res Commun. 2007 Jul 27; 359(2):379-84. PMID: 17543278; PMCID: PMC2062522.
    70. Lee SO, Chun JY, Nadiminty N, Lou W, Gao A. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Prostate. 2007 May 15; 67(7):764-73. PMID: 17373716.
      View in: PubMed
    71. Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao A. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate. 2006 Jul 01; 66(10):1070-5. PMID: 16637076.
      View in: PubMed
    72. Park SY, Kim YJ, Gao A, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY, Park YM. Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res. 2006 May 15; 66(10):5121-9. PMID: 16707435.
      View in: PubMed
    73. Nadiminty N, Lou W, Lee SO, Lin X, Trump DL, Gao A. Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A. 2006 May 09; 103(19):7264-9. PMID: 16651533; PMCID: PMC1464331.
    74. Liu J, Zhong X, Zhou Q, Gao A, Wang Y, Zhu W, Ma L, Zhang Z. [Primary experimental results of methylseleninic acid on the proliferation inhibition and apoptotic induction in human high-metastatic large cell lung cancer cell line L9981]. Zhongguo Fei Ai Za Zhi. 2006 Apr 20; 9(2):103-8. PMID: 21144291.
      View in: PubMed
    75. Chun JY, Nadiminty N, Lee SO, Onate SA, Lou W, Gao A. Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer. Mol Cancer Ther. 2006 Apr; 5(4):913-8. PMID: 16648561.
      View in: PubMed
    76. Nadiminty N, Lou W, Lee SO, Mehraein-Ghomi F, Kirk JS, Conroy JM, Zhang H, Gao A. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2. Clin Cancer Res. 2006 Mar 01; 12(5):1420-30. PMID: 16533764.
      View in: PubMed
    77. Tan D, Wu X, Hou M, Lee SO, Lou W, Wang J, Janarthan B, Nallapareddy S, Trump DL, Gao A. Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol. 2005 Aug; 174(2):753-6. PMID: 16006970.
      View in: PubMed
    78. Lee SO, Lou W, Nadiminty N, Lin X, Gao A. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. Prostate. 2005 Jul 01; 64(2):160-7. PMID: 15678501.
      View in: PubMed
    79. Dong Y, Zhang H, Gao A, Marshall JR, Ip C. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Mol Cancer Ther. 2005 Jul; 4(7):1047-55. PMID: 16020662.
      View in: PubMed
    80. Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao A. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res. 2005 Apr 15; 65(8):3487-92. PMID: 15833885.
      View in: PubMed
    81. Zhang H, Dong Y, Zhao H, Brooks JD, Hawthorn L, Nowak N, Marshall JR, Gao A, Ip C. Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. Cancer Genomics Proteomics. 2005 Apr; 2(2):97-114. PMID: 18548127.
      View in: PubMed
    82. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, Cantarel BM, Vessella RL, Gao A, Petros J, Miura Y, Simons JW, Dong JT. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet. 2005 Apr; 37(4):407-12. PMID: 15750593.
      View in: PubMed
    83. Lee SO, Gao A. STAT3 and transactivation of steroid hormone receptors. Vitam Horm. 2005; 70:333-57. PMID: 15727810.
      View in: PubMed
    84. Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao A. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate. 2004 Sep 01; 60(4):303-9. PMID: 15264241.
      View in: PubMed
    85. Lee SO, Lou W, Johnson CS, Trump DL, Gao A. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. Prostate. 2004 Aug 01; 60(3):178-86. PMID: 15176047.
      View in: PubMed
    86. Xie TX, Wei D, Liu M, Gao A, Ali-Osman F, Sawaya R, Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene. 2004 Apr 29; 23(20):3550-60. PMID: 15116091.
      View in: PubMed
    87. Dong Y, Lee SO, Zhang H, Marshall J, Gao A, Ip C. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res. 2004 Jan 01; 64(1):19-22. PMID: 14729601.
      View in: PubMed
    88. Gao A, Lou W, Dong JT, Barrett JC, Danielpour D, Isaacs JT. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. Prostate. 2003 Dec 01; 57(4):256-60. PMID: 14601021.
      View in: PubMed
    89. Lee SO, Lou W, Hou M, Onate SA, Gao A. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene. 2003 Sep 11; 22(39):7981-8. PMID: 12970746.
      View in: PubMed
    90. Leman ES, DeMiguel F, Gao A, Getzenberg RH. Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells. J Urol. 2003 Jul; 170(1):235-40. PMID: 12796696.
      View in: PubMed
    91. De Miguel F, Lee SO, Onate SA, Gao A. Stat3 enhances transactivation of steroid hormone receptors. Nucl Recept. 2003 Jun 13; 1(1):3. PMID: 12904256.
      View in: PubMed
    92. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao A, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003 Jan 23; 22(3):319-29. PMID: 12545153.
      View in: PubMed
    93. Lee SO, Lou W, Hou M, de Miguel F, Gerber L, Gao A. Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res. 2003 Jan; 9(1):370-6. PMID: 12538490.
      View in: PubMed
    94. DeMiguel F, Lee SO, Lou W, Xiao X, Pflug BR, Nelson JB, Gao A. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. Prostate. 2002 Jul 01; 52(2):123-9. PMID: 12111703.
      View in: PubMed
    95. Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao A. Stat3 activation in prostatic carcinomas. Prostate. 2002 Jun 01; 51(4):241-6. PMID: 11987152.
      View in: PubMed
    96. Ni Z, Lou W, Lee SO, Dhir R, DeMiguel F, Grandis JR, Gao A. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol. 2002 Apr; 167(4):1859-62. PMID: 11912448.
      View in: PubMed